Ifabotuzumab (Synonyms: KB004) |
カタログ番号GC69258 |
Ifabotuzumab(KB004)は、EphA3を標的とするIgG1κ抗体(KD=610 pM)です。 Ifabotuzumabは腫瘍細胞のアポトーシスを引き起こし、抗体依存性細胞介在性細胞毒作用(ADCC)を活性化して腫瘍血管系を破壊することができます。 IfabotuzumabはCCR10 +細胞の人間特発性肺線維症(IPF)を減少させ、肺線維化を改善することができます。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2147698-66-4
Sample solution is provided at 25 µL, 10mM.
Review for Ifabotuzumab
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Ifabotuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *